Kyprolis Approved for Multiple Myeloma
FRIDAY, July 20 (HealthDay News) — Kyprolis (carfilzomib) has been approved by the U.S. Food and Drug Administration to treat certain people with multiple myeloma who have already been given at least two prior therapies.